Complement Factor D Targeting Protects Endotheliopathy in Organoid and Monkey Models of COVID-19

Researchers developed an infection-competent human vascular organoid from PSCs for modeling endotheliopathy. Longitudinal serum proteome analysis identified aberrant complement signature in critically ill patients driven by the amplification cycle regulated by complement factor B and D.